GUEST

My SNMMI Overview

My Organizations
My Councils
My Committees

Nuclear Medicine Clinical Trial Group (NMCTG) Management Board

Committee Mission

To oversee the development of SNMMI Radiopharmaceutical Therapy Registry (RaPTR), that will provide the operational framework to support a community of practices committed to continuous patient centered imaging and therapy, practice transformation and innovation through ongoing data collection and quality improvement by developing best practices.

Committee Charges

  • Fully launch the RaPTR Registry by the end of 2025/early 2026.
  • Expand the registry capabilities to meet CMS/regulatory standards for becoming a Clinical Data Registry. (Underway)
  • Add more outcome measures to the REDCap modules. 

Committee Members

  • Heather Jacene, MD, FSNMMI (President)
  • Orhan Kemal Oz, MD, PhD (Chairperson)
  • Ruth Lim, MD (Board Liaison)
  • Jin Cheung (Committee Member)
  • Marianna Dakanali, PhD (Committee Member)
  • David W. Dick, PhD (Committee Member)
  • Mehdi Djekidel, MD, FSNMMI (Committee Member)
  • Salman Hasan (Committee Member)
  • Alex Michael Heglin (Committee Member)
  • Joshua D. Juganaru (Committee Member)
  • Jennifer Kwak, MD (Committee Member)
  • Ismaheel Lawal, MD, PhD (Committee Member)
  • Daniel Lee, MD (Committee Member)
  • Ephraim E. Parent, MD, PhD (Committee Member)
  • Anthony Michael Rossi (Committee Member)
  • Bital Savir-Baruch, MD, MBA, FACNM (Committee Member)
  • Peter J.H. Scott, PhD, FSNMMI (Committee Member)
  • Divya Yadav (Committee Member)